Related Experiment Videos
[Calcium-phosphate metabolism in chronic polyarthritis]
Zeitschrift Fur Rheumatologie
|January 1, 1982
Summary
Rheumatoid arthritis patients show elevated calcitonin (CT) levels, suggesting it may counterbalance bone-damaging factors. Parathyroid hormone (PTH) and vitamin D do not appear to drive bone changes in this condition.
Area of Science:
- Rheumatology
- Endocrinology
- Bone Metabolism
Context:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting joints.
- Osseous changes and calcium-phosphate metabolism disturbances are common in RA.
- Previous studies have explored the roles of various hormones in RA pathogenesis.
Purpose:
- To investigate radiological and scintigraphic osseous changes in RA patients.
- To assess calcium-phosphate metabolism, including serum levels of magnesium, calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D3 (25-OH-D3), parathyroid hormone (PTH), and calcitonin (CT).
Summary:
- Twenty RA patients were evaluated for joint and osseous alterations.
- Serum levels of magnesium, calcium, phosphate, alkaline phosphatase, 25-OH-D3, and PTH were within normal ranges.
- Significantly elevated plasma calcitonin (CT) levels were observed in RA patients with normal renal function compared to controls (p < 0.01).
Impact:
- Findings suggest that PTH and 25-OH-D3 do not significantly contribute to osseous changes in RA.
- Elevated CT levels may act as a compensatory mechanism against osteolytic factors in RA.
- This research provides insights into the complex hormonal regulation of bone metabolism in rheumatoid arthritis.